Tag Archive for: in vitro diagnostics

IVDBO: Blood Screening Diagnostics 2024 Market Insights

Welcome to our latest blog, created in collaboration with The Scott Partnership Ltd., a renowned UK-based global marketing and communications agency specializing in the life sciences, healthcare, and technology sectors. Originally published on their platform, this blog marks the beginning of an exciting ongoing partnership with more blogs to come. In Vitro Diagnostics Business Outlook’s […]

IVD Trends to Watch: Coagulation Market to Reach $3.2 Billion and 920 Million Procedures in 2029

The global market for in vitro diagnostic (IVD) laboratory coagulation products is forecast to grow steadily, driven by the increasing volume of surgical procedures, the widespread adoption of enhanced post-surgical monitoring activities, and increasing applications in surgical, inpatient, and emergency care settings. According to the October 2024 market report IVD Test Procedure Volumes, 2024-2029 by […]

IVD Trends to Watch: $12 Billion Immunoassays Market Set for Growth Through 2029

Immunoassays, which are tests based on the binding of antibodies to antigens to identify the presence of a substance (an analyte), have been a cornerstone of clinical lab medicine since the mid-1960s. These tests, whether automated, manual, ELISAs, enzyme immunoassays, bead arrays, microarrays, or those using mass spectrometry, play a dominant role in laboratory medicine. […]

IVD Trends to Watch: Breakthroughs in Histology and Cytology

Histology and cytology, foundational pillars of pathological labs, play a critical role in diagnosing a variety of diseases, including cancer. With innovations enhancing diagnostic accuracy, efficiency, and patient outcomes, the industry is poised for significant growth and transformation in the coming years. In the report, Histology and Cytology IVD Market Update, 2024, Kalorama Information’s research […]

IVD Trends to Watch: The Evolution of Point-of-Care (POC) Diagnostic Testing

In 2023, point-of-care (POC) diagnostic testing market sales reached $36.8 billion, fueled by both professional and self-testing, according to Kalorama Information’s April 2024 report The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition. The POC diagnostic testing market continues to expand thanks to emerging technologies and increasing demand that will drive growth into the […]

IVD Trends to Watch: AI and the Future of Digital Pathology

Artificial intelligence (AI) is growing at a fast pace due to the adoption of AI-based technologies. There is a move toward connected health, which includes AI. AI has proved to be an invaluable tool in assisting physicians in caring for their patients. The advanced capabilities of algorithms are serving to reduce workloads and provide testing […]

Immunoassays: A $27 Billion Market of Intrigue and Opportunity

The global market for lab-based immunoassays, inclusive of both infectious disease and non-infectious disease analytes and instruments, reached $27 billion in 2023 and is forecast to experience modest growth in the foreseeable future. The findings are based on data published in In Vitro Diagnostics Business Outlook, 2024, a bi-monthly newsletter focused on global IVD products […]

IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth

In Egypt, like many other countries, the elderly population is growing rapidly, increasing at a rate of 5.1% annually, which is more than double the growth rate of the total population. This demographic shift, coupled with a large rural population requiring satellite care and mobile services, poses significant challenges for the healthcare system, according to […]

Momentum in Multiplex Testing for IVD

Diagnostic testing is now a cornerstone of healthcare, assisting physicians in diagnosing conditions and prescribing treatments. Demand for in vitro diagnostic (IVD) testing has remained strong across various segments, with sales generally increasing throughout 2023. Global IVD market sales surpassed $100 billion in 2023, according to In Vitro Diagnostic (IVD) Trends and Market Update: March […]

Cancer, Obesity, Diabetes, and Cardiovascular Disease Drive South Korea’s IVD Investment

South Korea ranks as the fifth largest health market in the Asia Pacific region, following China, Japan, Australia, and India.. South Korea’s investment in healthcare, medical devices, and diagnostics is driven by the burden of obesity, diabetes, cardiovascular disease, and cancer. The country’s business environment for medical devices and equipment is favorable and streamlined for […]